- Email: [email protected]
Corrigendum to “A live attenuated strain of Yersinia pestis as a vaccine against plague” [Vaccine 29 (2011) 2986–2998]
Vaccine 29 (2011) 5820
Contents lists available at ScienceDirect
Vaccine journal homepage: www.elsevier.com/locate/vaccine
Corrigendum
Corrigendum to “A live attenuated strain of Yersinia pestis as a vaccine against plague” [Vaccine 29 (2011) 2986–2998] Wei Sun a , David Six b , Xiaoying Kuang a , Kenneth L. Roland a , Christian R.H. Raetz b , Roy Curtiss III a,∗ a b
Center for Infectious Disease and Vaccinology, The Biodesign Institute, Arizona State University, Tempe, AZ 85287, USA Department of Biochemistry, Duke University Medical Center, Box 3711 DUMC, Durham, NC 27710, USA
a r t i c l e
i n f o
Article history: Received 9 June 2011 Accepted 9 June 2011 Available online 20 June 2011
The authors regret that there were some errors in the text. In the second paragraph of page 2992, 10015(pCD1Ap) (Pgm− lpxP32::PlpxL lpxL) should read: 10015(pCD1Ap) (lpxP32::PlpxL lpxL). The authors wish to apologize for an omission in the Acknowledgements section. The Acknowledgements section should read as follows: Acknowledgements The authors wish to thank Dr. C. Michael Reynolds for his valuable assistance in performing Mass spectra data (Fig. 2A and C), Dr. Susan Straley for providing anti-YopM antibodies and Dr. Praveen Alamuri for his valuable assistance in performing animal experiments. Conflict of interest: All authors declare none. Funding: This work was supported by National Institutes of Health grant 5R01 AI057885 to R.C. and by grant GM51310 to C.R.H.R. The mass spectrometry facility in the Department of Biochemistry of the Duke University Medical Center is supported by the LIPID MAPS Large Scale Collaborative Grant number GM-069338 from NIH.
DOI of original article:10.1016/j.vaccine.2011.01.099. ∗ Corresponding author at: The Biodesign Institute, Center for Infectious Diseases and Vaccinology, Arizona State University, PO Box 875401, 1001 S. McAllister Avenue, Tempe, AZ 85287-5401, USA. Tel.: +1 480 727 0445; fax: +1 480 727 0466. 0264-410X/$ – see front matter © 2011 Elsevier Ltd. All rights reserved. doi:10.1016/j.vaccine.2011.06.021
Contents lists available at ScienceDirect
Vaccine journal homepage: www.elsevier.com/locate/vaccine
Corrigendum
Corrigendum to “A live attenuated strain of Yersinia pestis as a vaccine against plague” [Vaccine 29 (2011) 2986–2998] Wei Sun a , David Six b , Xiaoying Kuang a , Kenneth L. Roland a , Christian R.H. Raetz b , Roy Curtiss III a,∗ a b
Center for Infectious Disease and Vaccinology, The Biodesign Institute, Arizona State University, Tempe, AZ 85287, USA Department of Biochemistry, Duke University Medical Center, Box 3711 DUMC, Durham, NC 27710, USA
a r t i c l e
i n f o
Article history: Received 9 June 2011 Accepted 9 June 2011 Available online 20 June 2011
The authors regret that there were some errors in the text. In the second paragraph of page 2992, 10015(pCD1Ap) (Pgm− lpxP32::PlpxL lpxL) should read: 10015(pCD1Ap) (lpxP32::PlpxL lpxL). The authors wish to apologize for an omission in the Acknowledgements section. The Acknowledgements section should read as follows: Acknowledgements The authors wish to thank Dr. C. Michael Reynolds for his valuable assistance in performing Mass spectra data (Fig. 2A and C), Dr. Susan Straley for providing anti-YopM antibodies and Dr. Praveen Alamuri for his valuable assistance in performing animal experiments. Conflict of interest: All authors declare none. Funding: This work was supported by National Institutes of Health grant 5R01 AI057885 to R.C. and by grant GM51310 to C.R.H.R. The mass spectrometry facility in the Department of Biochemistry of the Duke University Medical Center is supported by the LIPID MAPS Large Scale Collaborative Grant number GM-069338 from NIH.
DOI of original article:10.1016/j.vaccine.2011.01.099. ∗ Corresponding author at: The Biodesign Institute, Center for Infectious Diseases and Vaccinology, Arizona State University, PO Box 875401, 1001 S. McAllister Avenue, Tempe, AZ 85287-5401, USA. Tel.: +1 480 727 0445; fax: +1 480 727 0466. 0264-410X/$ – see front matter © 2011 Elsevier Ltd. All rights reserved. doi:10.1016/j.vaccine.2011.06.021